fromwww.theguardian.com
4 days agoIllegal weight-loss drugs being sold in UK by firms with high Trustpilot scores
Retatrutide, which has not yet completed clinical trials, is an experimental injection developed by the US drugmaker Eli Lilly that targets three gut hormones: GLP-1, GIP and glucagon. Early studies suggest it could help patients lose up to a quarter of their body weight, leading to it being hailed online as the next Ozempic. Ozempic is not licensed in the UK as a weight-loss drug. Buying Retatrutide illegally, however, carries serious risks.
Public health